General
Preferred name
BUTORPHANOL
Synonyms
Butorphanol-(+)-Tartrate (Schedule Iv) ()
BUTORPHANOL TARTRATE ()
LEVO-BC-2627 ()
Stadol NS ()
Butorphanol tartrate preservative free ()
Stadol preservative free ()
Butorphanol tartrate civ ()
Torbugesic ()
LEVO-BC-2627 Tartrate ()
Torbutrol ()
Stadol ()
Dolorex ()
Butorphanol (tartrate) ()
P&D ID
PD009892
CAS
42408-82-2
Tags
available
drug
Approved by
FDA
First approval
1978
Drug indication
Analgesic
Antitussive
Pain
Drug Status
approved
vet_approved
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Our representation of this drug and that contained in the ChEMBL and PubChem links exactly matches the structure in the INN record for butorphanol. PubChem CID 6916249 shows a different stereoisomer. (GtoPdb)
Compound Sets
11
Cayman Chemical Bioactives
ChEMBL Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
NCATS Inxight Approved Drugs
ReFrame library
External IDs
38
Properties
(calculated by RDKit )
Molecular Weight
327.22
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
2
Rotatable Bonds
2
Ring Count
5
Aromatic Ring Count
1
cLogP
3.37
TPSA
43.7
Fraction CSP3
0.71
Chiral centers
3.0
Largest ring
6.0
QED
0.88
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Therapeutic Class
Analgesics
Source data